- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04020406
Antibacterial Activity of Urea Against Ocular Bacteria
In Vitro Evaluation of Antibacterial Activity of Urea Solution Against Ocular Bacterial Isolates
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
In vitro susceptibility testing was performed with commercially available antibiotic discs, homemade urea discs saturated with urea solution at a concentration of 96 mmol. The weight of urea in one drop = 0.37 mg, in one ml = 10.34 mg (5 microliter/ disc) discs and combined discs (antibiotic discs to which urea solution was added). Combined discs provided better in vitro susceptibility results than antibiotics alone.
Scanning electron micrographs of bacterial isolates incubated overnight with urea solution showed marked disruption of bacterial aggregative patterns and irregularities of their cell walls.
Western blotting showed marked reduction in total proteins in bacterial isolates incubated overnight with urea solution. These findings may explain the possible mechanisms for antibacterial activity of urea solution as a result of protein denaturation.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Assiut, Egypt
- Hassan Lotfy Fahmy
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- ocular infection
Exclusion Criteria:
- Local antibiotics treatment
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Antibacterial Activity of Urea
Activity of Urea Solution against Ocular Bacterial Isolates
|
Antibacterial Activity of Urea Solution against Ocular Bacterial Isolates
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Antibacterial effect of Urea Solution against Ocular Bacterial
Time Frame: 6 month
|
Samples were both inoculated on Muller Agar (Sigma-Aldrich) plates and directly examined under the microscope using Gram stained smears. Inoculated plates were incubated at 37oC for 48 hrs. Gram negative isolates were sub-cultured on MacConkey's, Eosin Methelyene Blue (EMB) and Cystine Lactose Electrolyte Deficient (CLED) agar plates (Sigma-Aldrich). Gram positive isolates were sub-cultured on Mannitol Salt agar plates (Sigma-Aldrich). |
6 month
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Hassan 58 Lotfy, Professor, Assiut T
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2323297
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urea in Blood; High
-
The University of Texas Health Science Center,...Tufts University; American Heart Association; Michael and Susan Dell FoundationRecruitingNutrition in High-Risk PregnancyUnited States
-
Weizmann Institute of ScienceUniversity of Naples; Schneider Children's Medical Center, IsraelActive, not recruitingDiet Habit | Glucose, High Blood | Personalized Nutrition In ChildrenIsrael
-
Women's College HospitalHealth Quality OntarioCompletedHigh-risk Prescribing in Nursing HomesCanada
-
Cairo UniversityUnknownClass I Cavities in High Caries RiskEgypt
-
Macao Polytechnic UniversityRecruitingHigh-altitude Training Adaptations in Adolescent Male RowersChina
-
Zagazig UniversityEnrolling by invitationAchievement of High-quality Analgesia in Elbow SurgeriesEgypt
-
St George's, University of LondonUnknownAirway Morbidity | High Flow Oxygen in Rapid Sequence InductionUnited Kingdom
-
Omar HamdyCompletedNurses' Knowledge of High-alert Medications in Pediatric CareEgypt
-
Erzurum Technical UniversityCompletedHealthy Lifestyle Behaviors in High School StudentsTurkey (Türkiye)
-
B. Braun Melsungen AGCompletedAdult Patients in Need of High-energy Oral Nutritional SupplementationUnited Kingdom
Clinical Trials on Antibacterial Activity
-
The First Hospital of Jilin UniversityRecruitingPersistent HR-HPV Infection of the CervixChina
-
University of PernambucoCompleted
-
Seoul National University HospitalKorea Health Industry Development Institute; Medical Research Collaborating... and other collaboratorsCompleted
-
Özkan KasapCompletedVancomycin-Resistant EnterococcusTurkey (Türkiye)
-
Institut Claudius RegaudJanssen-Cilag Ltd.CompletedGlioblastoma MultiformeFrance
-
Hadassah Medical OrganizationCompleted
-
University of California, San DiegoColgate PalmoliveCompletedSurvival of Bacteria on Skin After Using Different SoapsUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityActive, not recruitingCIED Infection | TYRX Absorbable Antibacterial EnvelopeChina
-
Chinese University of Hong KongCompletedHepatocellular CarcinomaHong Kong
-
Istituto Scientifico Romagnolo per lo Studio e...TerminatedRecurrent Disease | DLBCL | MCLItaly